Investigating biomarkers related to Alzheimer's disease in older adults
Biomarker Core
This study is looking at different biological markers in people, especially those at risk for or in the early stages of Alzheimer's disease, to better understand how age affects the disease and to help improve future research on Alzheimer's and similar conditions.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10889963 on NIH RePORTER |
What this research studies
This research focuses on acquiring and analyzing various biomarkers, including biofluids and imaging data, to understand their relevance to Alzheimer's disease (AD) and the age-related factors influencing its development and progression. A team of experts in genomics, proteomics, metabolomics, and imaging will collaborate to gather data from participants, particularly those at high risk or in early stages of AD. The goal is to standardize these biomarker analyses to support ongoing research and improve understanding of AD and related dementias.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older, particularly those showing early signs of Alzheimer's disease or at high risk for developing it.
Not a fit: Patients who are younger than 65 or those without any risk factors or symptoms of Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and understanding of Alzheimer's disease, potentially enhancing treatment options for patients.
How similar studies have performed: Previous research has shown success in using biomarkers for understanding Alzheimer's disease, indicating that this approach is promising and builds on established methodologies.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Song, Allen W — Duke University
- Study coordinator: Song, Allen W
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.